Key Takeaways
- Shares reached an unprecedented peak of $808.80 Thursday, settling at $777.17 by market close
- Recent addition to the S&P 500 index triggered significant fund and ETF purchases
- Analysts boosted price projections substantially, with increases reaching as high as 66%
- Q2 results exceeded expectations with earnings per share of $1.67 versus the anticipated $1.41, while revenues climbed 65.5% compared to the prior year
- Company revealed plans for a 240,000 square foot North Carolina manufacturing site focused on AI data center lasers, counting Nvidia among its clientele
Shares of Lumentum (LITE) climbed to an unprecedented $808.80 Thursday before retreating to settle at $777.17. During pre-market trading on March 26, the stock was down 3.49%, trading at $750.
The remarkable ascent has been propelled by a combination of bullish analyst sentiment, S&P 500 membership, robust quarterly results, and a significant new manufacturing initiative.
The optical and photonics company unveiled intentions to establish a cutting-edge laser production complex in Greensboro, North Carolina. The expansive 240,000 square foot property was purchased from chip manufacturer Qorvo (QRVO) and will focus on InP-based optical solutions, featuring continuous wave lasers and ultra-high-power systems.
Nvidia (NVDA) has been confirmed as a key customer for this facility. Full-scale production operations are anticipated to commence in mid-2028.
The company indicated it will commit hundreds of millions of dollars to the location over the coming years. According to Lumentum, the initiative will both maintain and generate more than 400 manufacturing positions in the United States.
CEO Michael Hurlston stated: “Our customers are building the infrastructure that will define the next era of computing. Adding this new InP manufacturing facility significantly expands our capacity, deepens our strategic partnerships, and ensures we can deliver the performance, reliability, and scale required for the AI revolution.”
Wall Street Upgrades and Index Membership
A flurry of bullish revisions from financial analysts contributed to LITE’s impressive climb. B. Riley shifted its stance from neutral to buy while dramatically increasing its price objective from $147 to $526. JPMorgan established a $565 target alongside an overweight designation. Citigroup moved to $560 with a buy recommendation. UBS elevated its forecast from $215 to $455 while maintaining a neutral stance. Morgan Stanley boosted its projection to $595 but retained an equal weight position.
The consensus among Wall Street analysts currently stands at $575.06, with the stock receiving two strong buy ratings, eleven buy recommendations, and six hold ratings.
Lumentum gained entry to the S&P 500 recently, a development that traditionally generates passive buying pressure from benchmark funds and exchange-traded products. This technical buying likely contributed significantly to the stock’s upward trajectory.
Strong Quarterly Performance and Valuation Concerns
During its latest reporting period, the company delivered earnings per share of $1.67, surpassing Wall Street’s $1.41 projection. Total revenue reached $665.50 million, representing a 65.5% year-over-year increase and exceeding the $646.74 million forecast. Management has provided Q3 2026 EPS guidance in the range of $2.15 to $2.35.
However, some warning signs exist. The shares currently command a price-to-earnings ratio of 238, representing a significant premium by most valuation standards. Corporate insiders have been reducing holdings — CFO Wajid Ali divested 5,302 shares in late February at approximately $691.13 per share, with insiders collectively selling 65,775 shares during the previous 90 days.
Institutional ownership accounts for 94.05% of outstanding shares. Vanguard, Arrowstreet Capital, and Geode Capital have all expanded their stakes in recent reporting periods.
The 50-day moving average rests at $567.66, while the 200-day average stands at $363.11 — both considerably beneath current price levels.


